AI assistant
Sending…
ATAI Life Sciences N.V. — Director's Dealing 2021
May 24, 2021
32049_dirs_2021-05-24_bc5081f4-8094-4490-b3ec-cacf7f01e45f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IntelGenx Technologies Corp. (IGXT)
CIK: 0001098880
Period of Report: 2021-05-14
Reporting Person: ATAI Life Sciences B.V. (10% Owner)
Reporting Person: ATAI Life Sciences AG (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.00001 par value per share | 37300000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant (Right to Buy) | $0.35 | 2024-05-14 | Common Stock, $0.00001 par value (22380000) | Direct | |
| Warrant (Right to Buy) | $ | 2024-05-14 | Common Stock, $0.00001 par value (130000000) | Direct | |
| Warrant (Right to Buy) | $ | Common Stock, $0.00001 par value () | Direct |
Footnotes
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
More from ATAI Life Sciences N.V.
Regulatory Filings
2026
Mar 20
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Nov 26
Interim / Quarterly Report
2025
Nov 12
Earnings Release
2025
Nov 12
Director's Dealing
2025
Nov 7